home / stock / ctxr / ctxr quote
Last: | $0.7326 |
---|---|
Change Percent: | 2.72% |
Open: | $0.697 |
Close: | $0.7326 |
High: | $0.738 |
Low: | $0.6813 |
Volume: | 581,041 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7326 | $0.697 | $0.7326 | $0.738 | $0.6813 | 581,041 | 04-25-2024 |
$0.7165 | $0.77 | $0.7165 | $0.7701 | $0.7 | 876,601 | 04-24-2024 |
$0.7673 | $0.74 | $0.7673 | $0.7996 | $0.731 | 672,270 | 04-23-2024 |
$0.7342 | $0.74 | $0.7342 | $0.7544 | $0.7 | 1,314,812 | 04-22-2024 |
$0.7544 | $0.81 | $0.7544 | $0.8236 | $0.7244 | 1,680,141 | 04-19-2024 |
$0.8055 | $0.98 | $0.8055 | $1.04 | $0.765 | 6,380,060 | 04-18-2024 |
$0.8162 | $0.7501 | $0.8162 | $0.8391 | $0.7451 | 861,257 | 04-17-2024 |
$0.7498 | $0.7585 | $0.7498 | $0.7627 | $0.73 | 484,226 | 04-16-2024 |
$0.7652 | $0.7878 | $0.7652 | $0.7878 | $0.75 | 727,366 | 04-15-2024 |
$0.7878 | $0.81 | $0.7878 | $0.83 | $0.78 | 627,393 | 04-12-2024 |
$0.8332 | $0.87 | $0.8332 | $0.8898 | $0.7001 | 876,771 | 04-11-2024 |
$0.8502 | $0.8603 | $0.8502 | $0.88 | $0.8303 | 828,642 | 04-10-2024 |
$0.8903 | $0.9537 | $0.8903 | $0.99 | $0.8606 | 889,400 | 04-09-2024 |
$0.961 | $0.985 | $0.961 | $0.9994 | $0.95 | 521,995 | 04-08-2024 |
$0.9994 | $0.937 | $0.9994 | $1.03 | $0.9 | 922,146 | 04-05-2024 |
$0.9482 | $0.96 | $0.9482 | $0.99 | $0.92 | 1,484,471 | 04-04-2024 |
$0.9649 | $0.975 | $0.9649 | $1.01 | $0.9599 | 985,678 | 04-03-2024 |
$0.9766 | $1.06 | $0.9766 | $1.07 | $0.93 | 1,732,869 | 04-02-2024 |
$1.03 | $0.91 | $1.03 | $1.07 | $0.9051 | 1,809,959 | 04-01-2024 |
$0.8973 | $0.81 | $0.8973 | $0.9303 | $0.805 | 1,277,931 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Citius Pharmaceuticals Inc. Company Name:
CTXR Stock Symbol:
NASDAQ Market:
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma PR Newswire National Cancer Institute (NCI)-designated research and treatment center City of Hope, in Duarte, CA , to ...
Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference PR Newswire CRANFORD, N.J. , April 4, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedic...
Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma PR Newswire FDA assigns Prescription Drug User Fee Act (PDUFA) target action date ...